Vita Therapeutics is included in Governor Hogan’s announcement of “Maryland’s Future 20” - a list of the state’s most innovative companies exhibiting great potential for success.

10
min read
November 17, 2020

Test

Media Contact
Douglas Falk, MS
Chief Executive Officer & Co-Founder
VITA Therapeutics
info@vita-therapeutics.com
Investor Relations Contact
Douglas Falk, MS
Chief Executive Officer & Co-Founder
VITA Therapeutics
info@vita-therapeutics.com
Investor Relations Contact
Douglas Falk, MS
Chief Executive Officer & Co-Founder
VITA Therapeutics
info@vita-therapeutics.com

Other news

Vita Therapeutics strengthens leadership team with four key additions.
March 22, 2022
5
min read
Vita Therapeutics receives Orphan Drug Designation from FDA for new novel treatment.
July 23, 2020
10
min read
Vita Therapeutics receives a $300K commercialization grant from Maryland Stem Cell Research Foundation (MSCRF) to advance VTA-110 for treatment of Limb-Girdle Muscular...
June 5, 2020
8
min read